• ML365: Precision Inhibition of TASK1 in Ion Channel Research

  2026-07-22

  ML365 offers unmatched selectivity and potency as a TASK1 inhibitor, enabling advanced neurophysiology and ion channel pharmacology research. Its proven efficacy in modulating neuroinflammation and cognitive outcomes differentiates it as a first-choice tool for translational studies targeting potassium channel function.

• I-BET151 (GSK1210151A): Technical Guide for BET Inhibition W

  2026-07-22

  I-BET151 (GSK1210151A) enables selective inhibition of BET bromodomains, supporting targeted modulation of gene expression in cancer biology and MLL-fusion leukemia research. It is best suited for preclinical workflows, such as apoptosis and cell cycle arrest assays, when robust and controlled BET pathway modulation is required. This compound is not appropriate for diagnostic or clinical applications.

• Doxycycline in Cancer Research: Mechanisms, Protocols, and I

  2026-07-21

  Explore how Doxycycline, a tetracycline antibiotic, is advancing cancer research through its unique antiproliferative and metalloproteinase inhibitory activities. This article delivers a rigorous analysis of recent innovations, protocol insights, and practical guidance for optimizing Doxycycline-based assays.

• Targeting Tau Ser356 Phosphorylation in Alzheimer’s: NUAK In

  2026-07-21

  Taylor et al. (2023) demonstrate that phosphorylation of tau at serine 356 is closely linked to Alzheimer’s disease progression and is abundant in neurofibrillary tangles. Their work shows that NUAK inhibition via WZ4003 can specifically reduce this pathogenic tau form in both mouse and human brain tissue, revealing differential responses and highlighting new therapeutic directions for tauopathies.

• Carvedilol: β-Adrenergic Receptor Antagonist in Regenerative

  2026-07-20

  Carvedilol stands out as a nonselective β-adrenergic receptor antagonist, offering unique advantages in cardiovascular and hematopoietic research. This article unpacks its protocol optimizations, troubleshooting strategies, and the critical implications of recent findings on hematopoietic regeneration.

• Angiotensin II in Vascular Remodeling & AAA Model Research

  2026-07-20

  Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) is the gold standard for modeling hypertension and vascular remodeling, powering everything from cellular senescence assays to in vivo abdominal aortic aneurysm (AAA) models. This guide delivers workflow refinements, troubleshooting, and actionable insights to unlock the full translational value of APExBIO’s high-purity Angiotensin II in cutting-edge cardiovascular studies.

• AMH–SMAD4 Pathway Regulates Granulosa Cell Fate in PCOS Rats

  2026-07-19

  This study demonstrates that anti-Müllerian hormone (AMH) regulates ovarian granulosa cell proliferation and apoptosis via the SMAD4 signaling pathway in a DHEA-induced rat model of polycystic ovary syndrome (PCOS). The findings clarify a molecular mechanism underlying granulosa cell dysfunction in PCOS, with implications for targeted research on follicular development.

• Next-Gen Ovalbumin mRNA Tools for Safer Vaccine Research

  2026-07-18

  This article explores the intersection of advanced mRNA capping technology and innovative lipid nanoparticle delivery systems, focusing on EZ Cap™ OVA mRNA as a precision immunogen for translational immunology. Integrating mechanistic insights and the latest breakthroughs in reducing inflammation with lipid nanoparticle carriers, the discussion guides researchers in designing robust, low-inflammation preclinical studies and sets a new standard for immune response modeling and vaccine development.

• 2-Hydroxypropyl-β-cyclodextrin: Solubility Protocols & QC Gu

  2026-07-17

  2-Hydroxypropyl-β-cyclodextrin addresses the persistent challenge of solubilizing poorly water-soluble, hydrophobic compounds—especially those with aromatic or phenyl groups—by forming inclusion complexes that enhance aqueous solubility. It is validated for use as a drug formulation excipient and solubility enhancer in pharmaceutical and biochemical research. Applications outside these domains are not supported by product documentation.

• L-Alanyl-L-Glutamine (B8228): Protocols and Workflow Best Pr

  2026-07-17

  L-Alanyl-L-Glutamine is a stable, water-soluble dipeptide supplement designed to support gastrointestinal barrier integrity and attenuation of gut-related inflammation in experimental and clinical workflows. It is best used where glutamine stability, solubility, and consistent intestinal barrier function are critical, but is not indicated for protocols requiring solubility in DMSO or ethanol.

• EMSC Transplantation Modulates Microglia via NF-κB/MAPK Afte

  2026-07-16

  This study demonstrates that ectomesenchymal stem cell (EMSC) transplantation shifts microglial polarization toward the anti-inflammatory M2 phenotype through inhibition of NF-κB and MAPK pathways, thereby reducing neuroinflammation and neuronal injury following intracerebral hemorrhage (ICH). The findings suggest EMSCs as a promising strategy for mitigating brain injury in hemorrhagic stroke, with clear mechanistic insights into immune modulation.

• Icatibant in Severe Viral Infections: Translational Insights

  2026-07-16

  The referenced letter explores the off-label use of icatibant, a bradykinin B2 receptor antagonist, in severe cases of viral infections such as hantavirus nephropathia epidemica and COVID-19 pneumonia. The findings highlight the mechanistic relevance of kinin-kallikrein system activation in viral pathogenesis and support further clinical investigation into targeted modulation of vascular permeability.

• Bismuth Subsalicylate: Mechanisms and Research Benchmarks

  2026-07-15

  Bismuth Subsalicylate is a well-characterized gastrointestinal research compound with verified prostaglandin synthase inhibition and stability under -20°C storage. Its high purity and insolubility profile make it valuable for gastrointestinal disorder and inflammation studies. This dossier details mechanism, validated benchmarks, and practical limitations for lab use.

• Polymyxin B Sulfate: Immunological Insights Beyond Infection

  2026-07-15

  Explore Polymyxin B sulfate as more than an antibiotic for bloodstream and urinary tract infections—this article unveils its nuanced roles in immune modulation and assay design, integrating fresh perspective from cutting-edge microbiome-immunotherapy research.

• Polyethylenimine Linear (PEI, MW 40,000): Innovations in Sca

  2026-07-14

  Discover how Polyethylenimine Linear (PEI), MW 40,000 revolutionizes transient gene expression for recombinant protein production and advanced DNA delivery. This article offers unique scientific insights, highlighting mechanistic innovations and practical strategies that set it apart from existing content.

444 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page